The present study demonstrated that patients with a serum ITGB6 level >0.5ng/ml were highly suspected to have lymph node metastasis or distant metastasis, indicating that ITGB6 might serve as a potential marker for the risk stratification of gastric cancer patients. Here, ITGB6 is linked to metastatic malignant neoplasm in the lymph nodes.